NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered “bad” LDL by roughly 50%

Leave a Reply

Your email address will not be published. Required fields are marked *

0 Comments
scroll to top